DE60142305D1 - Pharmazeutische zubereitung enthaltend n-ä2-(1,6,7,8-tetrahydro-2h-indenoä5,4 büfuran-8-yl)ethylüpropionamid ummantelt mit einer copolyvidon-enthaltenden, polyäthylenglykolfreien umhüllung - Google Patents
Pharmazeutische zubereitung enthaltend n-ä2-(1,6,7,8-tetrahydro-2h-indenoä5,4 büfuran-8-yl)ethylüpropionamid ummantelt mit einer copolyvidon-enthaltenden, polyäthylenglykolfreien umhüllungInfo
- Publication number
- DE60142305D1 DE60142305D1 DE60142305T DE60142305T DE60142305D1 DE 60142305 D1 DE60142305 D1 DE 60142305D1 DE 60142305 T DE60142305 T DE 60142305T DE 60142305 T DE60142305 T DE 60142305T DE 60142305 D1 DE60142305 D1 DE 60142305D1
- Authority
- DE
- Germany
- Prior art keywords
- copolyvidone
- coated
- indenoe4
- glycle
- büfuran
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2813—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000351223 | 2000-11-17 | ||
PCT/JP2001/010016 WO2002040054A1 (fr) | 2000-11-17 | 2001-11-16 | Preparation pharmaceutique contenant de la copolyvidone |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60142305D1 true DE60142305D1 (de) | 2010-07-15 |
Family
ID=18824316
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60142305T Expired - Lifetime DE60142305D1 (de) | 2000-11-17 | 2001-11-16 | Pharmazeutische zubereitung enthaltend n-ä2-(1,6,7,8-tetrahydro-2h-indenoä5,4 büfuran-8-yl)ethylüpropionamid ummantelt mit einer copolyvidon-enthaltenden, polyäthylenglykolfreien umhüllung |
Country Status (7)
Country | Link |
---|---|
US (3) | US20040018239A1 (de) |
EP (2) | EP1334732B1 (de) |
AT (1) | ATE469644T1 (de) |
AU (1) | AU2002214305A1 (de) |
CA (2) | CA2650698C (de) |
DE (1) | DE60142305D1 (de) |
WO (1) | WO2002040054A1 (de) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050220870A1 (en) * | 2003-02-20 | 2005-10-06 | Bonnie Hepburn | Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid |
JP2004339162A (ja) * | 2003-05-16 | 2004-12-02 | Shin Etsu Chem Co Ltd | 難溶性薬物を含む医薬用固形製剤とその製造方法 |
AU2004257864A1 (en) * | 2003-07-18 | 2005-01-27 | Santarus, Inc. | Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders |
EP1648416A4 (de) * | 2003-07-18 | 2012-03-28 | Santarus Inc | Pharmazeutische formulierungen zur hemmung der säuresekretion und herstellungs- und anwendungsverfahren |
US8993599B2 (en) * | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US20070292498A1 (en) * | 2003-11-05 | 2007-12-20 | Warren Hall | Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers |
CA2554271A1 (en) * | 2004-02-10 | 2005-08-25 | Santarus, Inc. | Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory agent |
MXPA06011820A (es) * | 2004-04-16 | 2006-12-15 | Santarus Inc | Combinacion de inhibidor de bomba de proton, agente regulador del ph y agente procinetico. |
US8815916B2 (en) * | 2004-05-25 | 2014-08-26 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US8906940B2 (en) * | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
ATE493973T1 (de) * | 2004-06-04 | 2011-01-15 | Teva Pharma | Irbesartan enthaltende pharmazeutische zusammensetzung |
US8039674B2 (en) | 2004-06-23 | 2011-10-18 | Ono Pharmaceutical Co., Ltd. | Compound having S1P receptor binding potency and use thereof |
TWI400220B (zh) * | 2004-09-13 | 2013-07-01 | Takeda Pharmaceutical | 光活性胺衍生物的製法 |
NZ564407A (en) | 2005-06-22 | 2011-03-31 | Takeda Pharmaceutical | Tablet containing hardly soluble active ingredient ((S)-N-[2-(1,6,7,S-tetrahydro-2H-indeno[5,4-b]furan-S-yl)ethyl]propionamide) |
TWI402261B (zh) | 2006-06-19 | 2013-07-21 | Takeda Pharmaceutical | 三環化合物及其醫藥組成物 |
US20090092658A1 (en) * | 2007-10-05 | 2009-04-09 | Santarus, Inc. | Novel formulations of proton pump inhibitors and methods of using these formulations |
CN104546746A (zh) * | 2013-10-28 | 2015-04-29 | 南京长澳医药科技有限公司 | 一种雷美替胺片剂及其制备工艺 |
US10931859B2 (en) | 2016-05-23 | 2021-02-23 | InSyte Systems | Light emitter and sensors for detecting biologic characteristics |
US10713458B2 (en) | 2016-05-23 | 2020-07-14 | InSyte Systems | Integrated light emitting display and sensors for detecting biologic characteristics |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1617328A1 (de) * | 1966-07-28 | 1971-06-03 | Knecht Adolf O Dr | Neue,zuckerfreie UEberzuege fuer Tabletten und Drageekerne |
JPS456558B1 (de) * | 1966-12-21 | 1970-03-05 | ||
US4999226A (en) * | 1988-06-01 | 1991-03-12 | Merrell Dow Pharmaceuticals Inc. | Pharmaceutical compositions for piperidinoalkanol-ibuprofen combination |
HUT54035A (en) * | 1989-06-22 | 1991-01-28 | Chinoin Gyogyszer Es Vegyeszet | Process for coating labile pharmaceutical active components for protecting from oxygen and humidity |
DE3928183A1 (de) * | 1989-08-25 | 1991-02-28 | Goedecke Ag | Lactamfreie cyclische aminosaeuren |
US5401562A (en) * | 1992-03-27 | 1995-03-28 | Fuji Photo Film Co., Ltd. | Paper material for photosensitive materials and method of producing the same |
FR2698560B1 (fr) * | 1992-11-30 | 1995-02-03 | Virbac Laboratoires | Principes actifs pulvérulents stabilisés, compositions les contenant, leur procédé d'obtention et leurs applications. |
CA2241666C (en) * | 1996-03-08 | 2007-11-06 | Takeda Chemical Industries, Ltd. | Tricyclic compounds, their production and use |
US6034239A (en) * | 1996-03-08 | 2000-03-07 | Takeda Chemical Industries, Ltd. | Tricyclic compounds, their production and use |
DK0971878T3 (da) * | 1997-02-27 | 2008-06-30 | Takeda Pharmaceutical | Aminforbindelser, fremstillingen og anvendelsen deraf som inhibitorer af amyloid-beta-produktion |
WO1998049171A1 (fr) * | 1997-04-28 | 1998-11-05 | Nitto Denko Corporation | Monomere optiquement actif, polymere cristallin liquide et element optique |
US6004582A (en) * | 1997-05-30 | 1999-12-21 | Laboratorios Phoenix U.S.A, Inc. | Multi-layered osmotic device |
EP1077691B1 (de) * | 1998-05-15 | 2008-09-10 | Warner-Lambert Company LLC | Gamma-aminobuttersäurederivate enthaltende, feste arzneimittel und verfahren zu ihrer herstellung |
US6348485B1 (en) * | 1998-06-09 | 2002-02-19 | Takeda Chemical Industries, Ltd. | Method for treating or preventing sleep disorders |
US6432448B1 (en) * | 1999-02-08 | 2002-08-13 | Fmc Corporation | Edible coating composition |
DE19961897A1 (de) * | 1999-12-20 | 2001-06-28 | Basf Ag | Verwendung eines Filmüberzuges als geschmacksmaskierendes Coating von pharmazeutischen Darreichungsformen |
US6248359B1 (en) * | 2000-01-05 | 2001-06-19 | Laboratorios Phoenix U.S.A., Inc. | Multi-tablet oxybutynin system for treating incontinence |
US6572890B2 (en) * | 2000-01-13 | 2003-06-03 | Osmotica Corp. | Osmotic device containing venlafaxine and an anti-psychotic agent |
-
2001
- 2001-11-16 CA CA2650698A patent/CA2650698C/en not_active Expired - Lifetime
- 2001-11-16 DE DE60142305T patent/DE60142305D1/de not_active Expired - Lifetime
- 2001-11-16 CA CA2428817A patent/CA2428817C/en not_active Expired - Lifetime
- 2001-11-16 AU AU2002214305A patent/AU2002214305A1/en not_active Abandoned
- 2001-11-16 US US10/416,172 patent/US20040018239A1/en not_active Abandoned
- 2001-11-16 EP EP01982812A patent/EP1334732B1/de not_active Expired - Lifetime
- 2001-11-16 WO PCT/JP2001/010016 patent/WO2002040054A1/ja active Application Filing
- 2001-11-16 EP EP10157935A patent/EP2305219A1/de not_active Withdrawn
- 2001-11-16 AT AT01982812T patent/ATE469644T1/de not_active IP Right Cessation
-
2009
- 2009-07-01 US US12/459,551 patent/US20090274733A1/en not_active Abandoned
-
2016
- 2016-08-11 US US15/234,604 patent/US10098866B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1334732A4 (de) | 2006-03-15 |
US20170020841A1 (en) | 2017-01-26 |
WO2002040054A1 (fr) | 2002-05-23 |
ATE469644T1 (de) | 2010-06-15 |
CA2428817A1 (en) | 2002-05-23 |
US10098866B2 (en) | 2018-10-16 |
CA2650698C (en) | 2013-05-28 |
US20040018239A1 (en) | 2004-01-29 |
EP1334732A1 (de) | 2003-08-13 |
CA2428817C (en) | 2010-06-01 |
EP2305219A1 (de) | 2011-04-06 |
US20090274733A1 (en) | 2009-11-05 |
AU2002214305A1 (en) | 2002-05-27 |
EP1334732B1 (de) | 2010-06-02 |
CA2650698A1 (en) | 2002-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60142305D1 (de) | Pharmazeutische zubereitung enthaltend n-ä2-(1,6,7,8-tetrahydro-2h-indenoä5,4 büfuran-8-yl)ethylüpropionamid ummantelt mit einer copolyvidon-enthaltenden, polyäthylenglykolfreien umhüllung | |
DE68902954D1 (de) | Waessrige ueberzugsemulsion fuer pharmazeutische dosierungsformen. | |
DE69832816D1 (de) | Orale pharmazeutische dosierungsform mit verlängerter wirkstofffreisetzung | |
DE69638364D1 (de) | Formulierungen mit kontrollierter abgabe (albuterol) | |
DE69013473D1 (de) | Cimetidin enthaltende Arzneimittel. | |
GR1002564B (el) | Στερεα απο του στοματος χορηγουμενη φαρμακευτικη μορφη δοσιμετρησεως προγραμματισμενου ρυθμου απελευθερωσεως. | |
DE60005819D1 (de) | Geschmacksmaskierte orale pharmazeutische zusammensetzungen mit kontrollierter abgabe | |
ATE334663T1 (de) | Arzneimittelzusammensetzung mit verzögerter wirkstoffabgabe | |
DE69229949D1 (de) | Diltiazem enthaltende arzneimittel mit verzögerter wirkstoffabgabe | |
ATE225165T1 (de) | Im unteren teil des verdauungstrakts freisetzende pharmazeutische zubereitung in form einer beschichteten kapsel | |
EA199700231A1 (ru) | Дозирующий ингалятор для албутерола | |
NO20022998D0 (no) | Farmasöytiske preparater som tilveiebringer foröket konsentrasjon av medikament | |
ATE250593T1 (de) | Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen | |
DE60211464D1 (de) | Pharmazeutische formulierungen mit kontrollierter wirkstoff-freigabe enthaltend milchsäure-polymer, sowie deren herstellung | |
ITMI913170A1 (it) | Composizione farmaceutica per uso oftalmico contenente un antiinfiammatorio non steroideo ed un decongestionante come principi attivi | |
WO2001041742A3 (en) | Antiviral medication | |
BR9610983A (pt) | Formas estáveis de administração farmacêuticas contendo paratormônio | |
ATE383868T1 (de) | Pharmazeutische formulierung enthaltend megalatran und dessen pro-pharmaka | |
ATE290854T1 (de) | Carbamazepinformulierung mit verzögerter freigabe | |
ATE304844T1 (de) | Entzündungshemmende pharmazeutische formulierungen | |
RS50298B (sr) | Direktno kompresibilna matrica za kontrolisano oslobađanje pojedinačnih dnevnih doza klaritromicina | |
DE50003454D1 (de) | Proteinenthaltende pharmazeutische zubereitung | |
ATE195940T1 (de) | Taxol derivate,deren herstellung und diese enthaltende pharmazeutische zusammenstellungen | |
WO2002028424A3 (en) | Kyberdrug as autovaccines with immune-regulating effects | |
ATE158172T1 (de) | Pulverförmige pharmazeutische zusammensetzung |